Erbitux cetuximab IMC-C225: Phase II

Researchers presented data from four trials of Erbitux in patients with advanced NSCLC. In a Phase II trial (LUCAS), the

Read the full 206 word article

How to gain access

Continue reading with a
two-week free trial.